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httpicense.Abstract Purpose: To study if glioma grade could be correlated with perfusion CT parameters;
permeability surface (PS) and cerebral blood volume (CBV) and if high-grade glioma would show
different parameter levels as compared with low-grade glioma.
Patients and methods: Perfusion CT (PCT) was conducted for 40 patients with untreated glioma
using 64 multidetector-row CT scanner. Perfusion maps of PS and CBV were generated, and these
parameters were measured. World Health Organization (WHO) glioma grades were compared with
PCT parameters.
Results: The 40 patients were classiﬁed as low-grade glioma group (18 patients) and high-grade gli-
oma group (22patients). There was highly signiﬁcant difference (P< 0.001) between the two groups
as regard the mean values of CBV& PS in tumor sides where they were higher in the high-grade
glioma group. Receiver operating characteristic (ROC) analyses showed that PS (AUC 0.818) is
better than CBV (AUC 0.788) in differentiating low- and high-grade glioma and so PS had higher
predictability than CBV regarding glioma grading.
Conclusion: Changes in PS and CBV values had good correlation with glioma grading; with PS was
the best parameter correlating with glioma grade. High grade glioma showed higher PS and CBV
levels as compared with low-grade glioma.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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Gliomas, the most common primary brain neoplasm in adults,
are very heterogeneous tumors. High-grade gliomas can be
highly invasive and extremely vascular tumors (1). Malignant
brain tumors are characterized by neovascularity and in-
creased angiogenic activity, with a higher proportion of imma-
ture and highly permeable vessels (2). Quantifying tumor
angioneogenesis and neovascularity is important in predicting
tumor grade, treatment options, treatment response, and prog-
nosis because it appears to play a central role in the growthProduction and hosting by Elsevier B.V. All rights reserved.
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450 K.A. Ahmad, A.M. Abd Elhameedand spread of tumors (3). Histopathologic micro vascular den-
sity has been used as the gold standard to assess this because of
its direct association with angiogenic growth factor expression,
tumor growth, and occurrence of metastases (3).
Glioma grading is currently based on the histologic assess-
ment of the tumor, which is achieved by either brain biopsy or
cytoreductive surgery; however, there are inherent limitations
with these techniques and their interpretation (2).
In vivo perfusion imaging techniques provide additional
information regarding tumor physiology and hemodynamics,
which may help in better characterizing glioma malignancy
and may also overcome some of the limitations of histologic
grading and conventional morphologic imaging. Perfusion
imaging has been used to assess tumor grade and prognosis
and, recently, to assess treatment response, which has attracted
more attention due to the advent of newer therapeutic options,
including antiangiogenic agents (4). Traditionally, perfusion
imaging of brain tumors has been performed with MR imag-
ing, by using various perfusion imaging techniques and esti-
mating tumor blood volume, blood ﬂow, and permeability
(2). However, perfusion CT (PCT), which has also been used
recently for glioma grading, (5,6) provides a linear relationship
between tissue attenuation and tissue concentration of a con-
trast agent, unlike perfusion MR imaging, and, hence, proba-
bly provides a more robust and less biased estimation of tumor
blood volume and tumor vascular leakiness parameters. So,
PCT potentially has advantages over MR perfusion because
of easy accessibility, faster scanning times, measurement of
absolute perfusion values, and relatively easy post processing
and low cost compared with MR perfusion (5,6).
The aim of our work was to study if glioma grade would be
correlated with perfusion CT parameters; permeability surface
(PS) and cerebral blood volume (CBV) and if high-grade gli-
oma would show different parameter levels as compared with
low-grade glioma.2. Patients and methods
This prospective study was carried out in Ibn-Sina hospital
MOH, State of Kuwait between January 2006 and June 2008.
PCT was conducted for 40 patients with untreated glioma; 24
males and 16 females, their age ranged from 34 to 65 years.
An informed consent was obtained from each patient before
the study. All patients underwent PCT before any treatment.3. Perfusion CT technique
Perfusion studies were performed using 64-section (VCT, GE
Healthcare) multi-detector–row CT scanners. A non-contrastTable 1 Perfusion CT parameters and ROC analysis for low- and
PCT parameter Low-grade glioma (18 patients) H
PS (ml/100 g/min)
Range 0.26–4.57 4
Mean ± SD 1.95 ± 1.52 8
CBV (ml/100 g)
Range 0.55–2.37 1
Mean ± SD 1.46 ± 0.63 3CT head study was done to localize the region of interest be-
fore obtaining a perfusion scan. For the perfusion scan,
40 ml of nonionic contrast was injected at a rate of 4 ml/s
through a 20-gauge intravenous line by using an automatic
pump injector. A volume (continuous) scanning was initiated
with the following technique: 80 kVp, 190–200 mA, and 1 s
per rotation for duration of 50 s. Axial sections were acquired,
resulting in a total coverage area of 4 cm. Perfusion maps of
PS and CBV were generated at an Advantage Windows work-
station 3.1 by using CT tumor perfusion software (GE Health-
care). We used the superior sagittal sinus or great cerebral vein
as the venous output function in all patients and the anterior
or middle cerebral artery (artery with the greatest peak and
slope on time–attenuation curves) as the arterial input func-
tion. A region of interest (ROI) was drawn within the conﬁnes
of a large vessel, and the automatic function of the software
picked the pixels with the greatest peak and slope on the
time–attenuation curve for analysis.
Permeability surface (PS) characterizes the diffusion of some
of the contrast agent from the blood vessels into the interstitial
space due to deﬁcient or leakyblood–brain barrier (BBB). Perme-
ability is related to the diffusion coefﬁcient of the contrast agent
in the assumed water-ﬁlled pores of the capillary endothelium.
CT examination was evaluated for the size and the extent of
the tumor on the basis of enhancing or non-enhancing solid
and necrotic/cystic parts, and this observation was used to help
guide drawing the regions of interest on PCT maps.
Regions of interest (ROI) were manually drawn to include
the solid portions of the tumor, taking care not to include ne-
crotic/cystic parts of the tumor, especially in higher grade tu-
mors, and also by avoiding any major cortical vessels on
each axial CT section. Values of perfusion CT parameters;
PS and CBV were recorded and compared to the contralateral
normal white matter as internal reference.
4. Statistical analysis
SPSS statistics (V. 19.0, IBM Corp., USA, 2010) was used for
data analysis. Data were expressed as mean ± SD for quanti-
tative parametric measures.
The following tests were done:
1. Comparison between two independent mean groups for
parametric data using Student t test.
2. Comparison between two dependent groups for parametric
data using Paired t test.
In addition, receiver operating characteristic (ROC) analy-
ses were constructed to obtain the most sensitive and speciﬁc
cutoff value for each parameter, to compute the area underhigh-grade glioma groups at tumor sides.
igh-grade glioma (22 patients) P value AUC
–19.5 <0.001 0.818
.54 ± 4.5
.75–7.28 <0.001 0.788
.78 ± 1.66
Fig. 1 Low grade glioma (A) Permeability surface (PS) tumor side shows increased permeability surface 1.75, (B) Cerebral blood volume
(CBV) increased CBV1.
Fig. 2 Recurrent low grade glioma (A) Permeability surface (PS) tumor side shows increased permeability surface 1.72, (B) Cerebral
blood volume (CBV) increased CBV1.13.
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help assess which parameter is the best in differentiating be-
tween different grades of glioma; the higher the AUC, the bet-
ter is the predictability of the parameter.
5. Results
We made PCT for 40 patients with glioma before any line of
treatment. Then, 24 patients underwent surgery and 16 pa-
tients had stereotactic biopsies obtained from the tumor. All
the histopathologic specimens were examined and graded as
per World Health Organization [WHO] guidelines. (5) We
classiﬁed patients into two groups:
(1) The low-grade glioma group, it comprised 18 patients;
14 males and 4 females. They had a mean age of
44.1 years ± 8.7(SD) years (range: 34–57 years).
(2) The high-grade glioma group, it comprised 22 patients;
10 males and 12 females. They had a mean age of
57.3 years ± 7.2 years (range: 43–65 years).
Patients of the low-grade group had grade II astrocytomas.
In the high-grade group, 6 patients had grade III anaplastic
astrocytomas and 16 patients had glioblastoma multiforme.Fig. 3 High grade glioma (A) Post contrast Axial CT scan at mid les
Permeability surface (PS) tumor side shows increased permeability suPerfusion CT parameters’ (CBV & PS) results for low- and
high-grade glioma groups at tumor sides were demonstrated in
(Table 1).
5.1. Low-grade glioma group (Figs. 1 and 2)
We found that CBV values detected from contralateral normal
white matter ranged from 0.62 to 3.27 ml/100 g, with a mean
value of 1.26 ± 0.77 ml/100 g, while CBV values detected from
tumor sides ranged from 0.55 to 2.37 ml/100 g, with a mean
value of 1.46 ± 0.63 ml/100 g, with no signiﬁcant difference
(P> 0.05) detected between the two sides.
PS values detected from contralateral normal white matter
ranged from 0.04 to 0.84 ml/100 g/min, with a mean value of
0.53 ± 0.30 ml/100 g/min, while PS values detected from tu-
mor sides ranged from 0.26 to 4.57 ml/100 g/min, with a mean
value of 1.95 ± 1.52 ml/100 g/min, with highly signiﬁcant dif-
ference (P< 0.001) detected between the two sides.
5.2. High-grade glioma group (Figs. 3–5)
We found that CBV values detected from contralateral normal
white matter ranged from 0.85 to 3.47 ml/100 g, with a mean
value of 1.74 ± 0.90 ml/100 g, while CBV values detected fromion area (B) Cerebral blood volume (CBV) increased CBV 6.77 (C)
rface 13.9.
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value of 3.78 ± 1.66 ml/100 g, with highly signiﬁcant differ-
ence (P< 0.001) detected between the two sides.
PS values detected from contralateral normal white matter
ranged from 0.21 to 3.45 ml/100 g/min, with a mean value of
1.19 ± 1.14 ml/100 g/min, while PS values detected from tumor
sides ranged from 4 to 19.5 ml/100 g/min, with a mean value of
8.54 ± 4.5 ml/100 g/min, with highly signiﬁcant difference
(P< 0.001) detected between the two sides.
In investigating the possible statistical signiﬁcance between
the two groups, we found that: There was highly signiﬁcant
difference (P< 0.001) between the two groups as regard the
mean values of CBVandPS in tumor sides where they are higher
in the high-grade glioma group as the mean value of CBV in
low-grade group = 1.46 ± 0.63 ml/100 g, while the mean value
of CBV in high-grade group = 3.78 ± 1.66 ml/100 g. And the
mean value of PS in low-grade group = 1.95 ± 1.52 ml/100 g/
min, while the mean value of PS in high-grade group =
8.54 ± 4.5 ml/100 g/min.Fig. 4 High grade glioma (A) Post contrast Axial CT scan at mid lesi
Permeability surface (PS) tumor side shows increased permeability surAlso, there was no signiﬁcant difference (P> 0.05) be-
tween the two groups as regard the mean value of CBV in con-
tralateral normal white matter, while there was a signiﬁcant
difference (P< 0.05) between the two groups as regard the
mean value of PS in contralateral normal white matter where
it is higher in the high-grade glioma group.
6. By using diagnostic validity test (Table 2)
We found that the best cut-off value of CBV parameter for dis-
crimination between high and low grade glioma is 2.08 ml/
100 g (i.e. >2.08 identify high grade glioma & <2.08 identify
low grade glioma) with sensitivity = 81.82%, speciﬁcity =
88.89%, positive predictive value = 90%, negative predictive
value = 80% and efﬁcacy or diagnostic accuracy = 85%.
We found that the best cut-off value of PS parameter for
discrimination between high and low grade glioma is 3.6 ml/
100 g/min (i.e. >3.6 identify high grade glioma & <3.6 iden-
tify low grade glioma) with sensitivity = 100%, speciﬁcity =on area (B) Cerebral blood volume (CBV) increased CBV 2.21 (C)
face 6.37.
Fig. 5 High grade glioma (A) Post contrast Axial CT scan at mid lesion area (B) Cerebral blood volume (CBV) increased CBV 6.13 (C)
Permeability surface (PS) tumor side shows increased permeability surface 21.
Table 2 Results of diagnostic validity test.
PCT parameter Best cut-oﬀ
value
Sensitivity (%) Speciﬁcity (%) Positive predictive
value (%)
Negative predictive
value (%)
Eﬃcacy (%)
CBV (ml/100 g) 2.08 81.82 88.89 90 80 85
PS (ml/100 g/min) 3.6 100 88.89 91.67 100 95
454 K.A. Ahmad, A.M. Abd Elhameed88.89%, positive predictive value = 91.67%, negative predic-
tive value = 100% and efﬁcacy or diagnostic accuracy =
95% .
In addition, ROC analysis showed that PS (AUC 0.818) is
better than CBV (AUC 0.788) in differentiating low- and high-
grade glioma (Figs. 6 and 7) and so PS parameter had higher
predictability than CBV parameter.
7. Discussion
Increased vascular permeability has been associated with
malignant tumor micro vessels and has been evolving as asurrogate marker of tumor angiogenesis and thus tumor grade
(5). Higher permeability has been associated with higher tumor
grade (7) and has also been shown to decrease in response to
antiangiogenic therapy due to decreased tumor growth predict-
ing tumor response (5).
Perfusion imaging can provide information about ﬂow
dynamics of tumor vessels, particularly blood volume and per-
meability measurements that can be complementary to con-
ventional imaging for preoperative grading of gliomas (5).
In our study, we found that there was highly signiﬁcant
difference (P< 0.001) between the low and high-grade glioma
groups as regard the mean value of PS in tumor sides where it
Fig. 6 ROC curve analysis showing the diagnostic performance
of CBV for discriminating patients with high grade from those
with low grade glioma.
Fig. 7 ROC curve analysis showing the diagnostic performance
of PS for discriminating patients with high grade from those with
low grade glioma.
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PS in low-grade group = 1.95 ± 1.52 ml/100 g/min, while in
high-grade group = 8.54 ± 4.5 ml/100 g/min. These ﬁndings
are in agreement with that of Jain et al. in (5). Yet, the results
of PS values in our study were higher than their results.
Tumor neoangiogenesis increases the capillary attenuation
within the tumor. Increased capillary attenuation leads to
higher blood volume and blood ﬂow in the tumor bed (8).
In our study, there was highly signiﬁcant difference
(P< 0.001) between the two groups as regard the mean value
of CBV in tumor sides where it is higher in the high-grade gli-
oma group as the mean value of CBV in low-grade group =
1.46 ± 0.63 ml/100 g, while in high-grade group = 3.78 ±
1.66 ml/100 g. These ﬁndings are similar to that of Ellika
et al. in (6) as they found that the mean value of CBV of the
low and high-grade glioma group was 1.44 and 3.06 respec-
tively. And also in accordance with that of Jain et al. in (5),and Eastwood & Provenzalein, 2003 (9) yet, the results of
CBV values in our study were higher than their results.
Some authors used MR perfusion techniques in studying
brain glioma. They found various rCBV cut-off values in dif-
ferentiating between patients with low and high-grade gliomas.
Lev and Rosen (10), found a threshold of 1.5 with a sensitivity
and speciﬁcity of 100% and 69%, respectively. Law et al. (11),
showed a sensitivity and speciﬁcity of 95.0% and 57.5%,
respectively, by using 1.75 as the threshold value. Shin et al.
(12), described a threshold of 2.93, with a sensitivity of
90.9% and a speciﬁcity of 83.3%, and lastly Hakyemez et al.
(13), used a threshold of 2.00 to differentiate low- and high-
grade gliomas, with 100% sensitivity and 90.9% speciﬁcity.
In our study, we found that the best cut-off value of PCT
CBV parameter for discrimination between high and low grade
glioma is 2.08 ml/100 g (i.e. >2.08 identify high grade glioma &
<2.08 identify low grade glioma) with sensitivity = 81.82%,
speciﬁcity = 88.89%, positive predictive value = 90%, nega-
tive predictive value = 80% and efﬁcacy or diagnostic accu-
racy = 85%. These results are near to that of Ellika et al. in
(6) as they found that, by using an CBV value of >1.92, they
can discriminate between high and low grade glioma with a sen-
sitivity of 85.7% and a speciﬁcity of 100%.
We found that the best cut-off value of PS parameter for
discrimination between high and low grade glioma is 3.6 ml/
100 g/min (i.e. >3.6 identify high grade glioma & <3.6 iden-
tify low grade glioma)with sensitivity = 100%, speciﬁc-
ity = 88.89%, positive predictive value = 91.67%, negative
predictive value = 100% and efﬁcacy or diagnostic accu-
racy = 95%. No previous similar studies were found to be
compared with our results as regard the diagnostic validity test
for PCT PS values; as most of the literature regarding the util-
ity of perfusion imaging and which evaluated PS parameter for
glioma grading is based on various MR perfusion techniques.
Yet, Jain et al. in (5) found in their study by using ROC
analyses that both CBV (AUC 0.930) and PS (AUC 0.927)
were very similar to each other in differentiating low- and
high-grade glioma, that not in agreement with our results as
in our study ROC analysis showed that PS (AUC 0.818) is bet-
ter than CBV (AUC 0.788) in differentiating low- and high-
grade glioma and so PS parameter had higher predictability
than CBV parameter in glioma grading.
8. In conclusions
Our study showed that there was highly signiﬁcant difference
(P< 0.001) between the low- and high grade glioma groups
as regard the mean values of CBV and PS in tumor sides where
they are higher in the high-grade glioma group.
The best cut-off value of PS parameter for discrimination
between high and low grade glioma is 3.6 ml/100 g/min, which
gave the best sensitivity, speciﬁcity and efﬁcacy or diagnostic
accuracy (95%), while The best cut-off value of CBV parame-
ter for discrimination between high and low grade glioma is
2.08 ml/100 g, which gave the best sensitivity, speciﬁcity and
efﬁcacy or diagnostic accuracy (85%). Also ROC analysis
showed that PS (AUC 0.818) is better than CBV (AUC
0.788) in differentiating low- and high-grade glioma.
Accordingly, both PCT parameters PS and CBV had good
correlation with glioma grading; with PS parameter having
higher predictability than CBV parameter, and it was the best
456 K.A. Ahmad, A.M. Abd ElhameedPCT parameter in our study which was correlating with glioma
grade.
So, we can use both PCT parameters especially PS as imag-
ing biomarkers for quantitative evaluation of brain glioma
perfusion, with subsequent assessment of their grade and prog-
nosis and, so treatment response, which will help more in eval-
uation of the newer therapeutic agents, especially
antiangiogenic drugs.
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